Evidence map›Paper›PMID 34565340›Full record

ArticleBMC nephrology2021

LAMA2 and LOXL4 are candidate FSGS genes.

Poornima Vijayan, Saidah Hack, Tony Yao, Mohammad Azfar Qureshi, Andrew D Paterson, Rohan John, Bernard Davenport, Rachel Lennon, York Pei, Moumita Barua

Open access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Poornima Vijayan *Department of Molecular Genetics, University of Toronto, Toronto, Canada.
Saidah Hack *Division of Nephrology, University Health Network, Toronto, Canada.
Tony YaoDivision of Nephrology, University Health Network, Toronto, Canada.
Mohammad Azfar QureshiDivision of Nephrology, University Health Network, Toronto, Canada.
Andrew D PatersonDivision of Epidemiology and Biostatistics, Dalla Lana School of Public Health, Toronto, Canada.
Rohan JohnDepartment of Laboratory Medicine and Pathology, Toronto General Hospital, Toronto, Canada.
Bernard DavenportWellcome Centre for Cell-Matrix Research, Division of Cell-Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Rachel LennonWellcome Centre for Cell-Matrix Research, Division of Cell-Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
York PeiDivision of Nephrology, University Health Network, Toronto, Canada.
Moumita BaruaDepartment of Molecular Genetics, University of Toronto, Toronto, Canada. moumita.barua@uhn.ca.ORCID 0000-0003-0628-9071
University Health Network · CAManchester Academic Health Science Centre · GBUniversity of Toronto · CAToronto General Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFocal and segmental glomerulosclerosis (FSGS) is a histologic pattern of injury that characterizes a wide spectrum of diseases. Many genetic causes have been identified in FSGS but even in families with comprehensive testing, a significant proportion remain unexplained.

methodsIn a family with adult-onset autosomal dominant FSGS, linkage analysis was performed in 11 family members followed by whole exome sequencing (WES) in 3 affected relatives to identify candidate genes.

resultsPathogenic variants in known nephropathy genes were excluded. Subsequently, linkage analysis was performed and narrowed the disease gene(s) to within 3% of the genome. WES identified 5 heterozygous rare variants, which were sequenced in 11 relatives where DNA was available. Two of these variants, in LAMA2 and LOXL4, remained as candidates after segregation analysis and encode extracellular matrix proteins of the glomerulus. Renal biopsies showed classic segmental sclerosis/hyalinosis lesion on a background of mild mesangial hypercellularity. Examination of basement membranes with electron microscopy showed regions of dense mesangial matrix in one individual and wider glomerular basement membrane (GBM) thickness in two individuals compared to historic control averages.

conclusionsBased on our findings, we postulate that the additive effect of digenic inheritance of heterozygous variants in LAMA2 and LOXL4 leads to adult-onset FSGS. Limitations to our study includes the absence of functional characterization to support pathogenicity. Alternatively, identification of additional FSGS cases with suspected deleterious variants in LAMA2 and LOXL4 will provide more evidence for disease causality. Thus, our report will be of benefit to the renal community as sequencing in renal disease becomes more widespread.

Indexed as

AgedAge of OnsetBasement MembraneChromosome DisordersExome SequencingFemaleGenetic TestingGlomerulosclerosis, Focal SegmentalHeterozygoteHumansKidneyLamininMaleMiddle AgedMutationPedigreeLamininlaminin alpha 2LOXL4 protein, humanProtein-Lysine 6-OxidaseBasement membraneHereditary FSGSLAMA2LOXL4

Identifiers

PMID34565340
PMCPMC8474709
OpenAlexW3133786494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.